prostate cancer Archive — Page 1 of 9

Smiling bald man wearing glasses, a brown checked suit, white shirt, and patterned tie, standing with folded arms in a bright modern building interior.
June 15, 2026

When a scientist gets cancer

A cancer expert’s journey through his own diagnosis and care.

By Larry Marnett
Stylized illustration of a person examining a large yellow laboratory beaker with a magnifying glass, alongside a heart-rate symbol, measurement markings, and radiating chart-like lines.
May 11, 2026

Urine test better than MRI for monitoring low-risk prostate cancer in new study

The urine test offers a noninvasive option to determine which patients truly need to undergo a biopsy and which can avoid a potentially unnecessary and invasive procedure.

By Craig Boerner
Collage featuring a smartphone displaying “My Health At Vanderbilt,” a large orange “BIOPSY!!” title, a red notification badge, walnuts, music notes, an “IMPORTANT!” note, and a photo of labeled specimen tubes.
October 31, 2025

My doctor told me I have cancer. Why did I feel so relieved? It’s weird, but I have my reasons. Hear me out.

My wife summed it up: “You’re the happiest person I ever heard of who just found out he has cancer.”

By Wayne Wood
3D medical illustration of the male pelvis showing a glowing orange prostate with two textured tumor-like masses, surrounded by translucent anatomical structures.
February 3, 2025

Study shows urine test for prostate cancer could be used at home

The results are important because it could enable at-home testing and increased access to testing for patients undergoing telehealth care.

By Craig Boerner
(iStock image)
January 28, 2025

Inherited gene elevates prostate cancer risk in affected families

The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer.

By Craig Boerner
(iStock)
January 8, 2025

Worldwide experts release clinical recommendations for management of ATM cancer risk 

Researchers established decades ago that ataxia-telangiectasia mutated (ATM) heterozygotes are at an increased risk for cancer, there remains a need to provide clear guidance for clinicians.

By Tom Wilemon